PharmaMatch is a successful company in the European B-to-B generic pharmaceutical industry, focused on licensing of know how.
Pharma-Data has specialized for many years in the product development of pharmaceutical formulas in it’s dedicated R&D center in Athens, Greece.
Since its founding in 2007, EMP Levo has distinguished itself as a specialist in the international market for pharmaceutical products; generic-plus, added-value generics and niche formulations.
EMP Levo has since then successfully developed Levothyroxine Oral Solution. EMP Levo’s Levothyroxine Oral Solution is patent protected in EU and USA, while used by BP as reference product for the establishment of the relevant official monograph.
Levothyroxine OS has already been introduced in a number of countries and EMP is currently focusing on a global roll out.